Unknown

Dataset Information

0

Oral Administration of Gintonin Attenuates Cholinergic Impairments by Scopolamine, Amyloid-? Protein, and Mouse Model of Alzheimer's Disease.


ABSTRACT: Gintonin is a novel ginseng-derived lysophosphatidic acid (LPA) receptor ligand. Oral administration of gintonin ameliorates learning and memory dysfunctions in Alzheimer's disease (AD) animal models. The brain cholinergic system plays a key role in cognitive functions. The brains of AD patients show a reduction in acetylcholine concentration caused by cholinergic system impairments. However, little is known about the role of LPA in the cholinergic system. In this study, we used gintonin to investigate the effect of LPA receptor activation on the cholinergic system in vitro and in vivo using wild-type and AD animal models. Gintonin induced [Ca(2+)]i transient in cultured mouse hippocampal neural progenitor cells (NPCs). Gintonin-mediated [Ca(2+)]i transients were linked to stimulation of acetylcholine release through LPA receptor activation. Oral administration of gintonin-enriched fraction (25, 50, or 100 mg/kg, 3 weeks) significantly attenuated scopolamine-induced memory impairment. Oral administration of gintonin (25 or 50 mg/kg, 2 weeks) also significantly attenuated amyloid-? protein (A?)-induced cholinergic dysfunctions, such as decreased acetylcholine concentration, decreased choline acetyltransferase (ChAT) activity and immunoreactivity, and increased acetylcholine esterase (AChE) activity. In a transgenic AD mouse model, long-term oral administration of gintonin (25 or 50 mg/kg, 3 months) also attenuated AD-related cholinergic impairments. In this study, we showed that activation of G protein-coupled LPA receptors by gintonin is coupled to the regulation of cholinergic functions. Furthermore, this study showed that gintonin could be a novel agent for the restoration of cholinergic system damages due to A? and could be utilized for AD prevention or therapy.

SUBMITTER: Kim HJ 

PROVIDER: S-EPMC4588723 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Oral Administration of Gintonin Attenuates Cholinergic Impairments by Scopolamine, Amyloid-β Protein, and Mouse Model of Alzheimer's Disease.

Kim Hyeon-Joong HJ   Shin Eun-Joo EJ   Lee Byung-Hwan BH   Choi Sun-Hye SH   Jung Seok-Won SW   Cho Ik-Hyun IH   Hwang Sung-Hee SH   Kim Joon Yong JY   Han Jung-Soo JS   Chung ChiHye C   Jang Choon-Gon CG   Rhim Hyewon H   Kim Hyoung-Chun HC   Nah Seung-Yeol SY  

Molecules and cells 20150807 9


Gintonin is a novel ginseng-derived lysophosphatidic acid (LPA) receptor ligand. Oral administration of gintonin ameliorates learning and memory dysfunctions in Alzheimer's disease (AD) animal models. The brain cholinergic system plays a key role in cognitive functions. The brains of AD patients show a reduction in acetylcholine concentration caused by cholinergic system impairments. However, little is known about the role of LPA in the cholinergic system. In this study, we used gintonin to inve  ...[more]

Similar Datasets

| S-EPMC6155334 | biostudies-literature
| S-EPMC7431620 | biostudies-literature
| S-EPMC8068536 | biostudies-literature
| S-EPMC4120959 | biostudies-literature
2021-11-24 | PXD025620 | Pride
2015-02-12 | E-GEOD-65851 | biostudies-arrayexpress
2010-05-30 | GSE20447 | GEO
| S-EPMC5698429 | biostudies-literature
| S-EPMC4125179 | biostudies-literature
| S-EPMC5561919 | biostudies-other